Navigation Links
Marketing of Low Tar Cigarette Brand by BAT Unethical

An online study published in the Lancet has revealed how British American Tobacco (BAT), a leading cigarette manufacturer has been adopting a strategy to mask the toxicity of the manufactured cigarettes. //

In an audit conducted to review the internal documents of the company by Canadian researchers, it has been found that the cigarettes actually delivered elevated levels of tar and nicotine under real life situations, while in documentation, it was claimed to produce a low yield.

Furthermore, that BAT was aware that real life smokers actually draw twice as much of the puff volume of the International Standards Smoking (ISO) machine, commonly used in testing protocols. In spite of the above observation, the company had been found to hide the difference in marketing campaigns and labels printed on cigarette packs.

Alarmingly, these cigarettes with high tar and nicotine yield were projected as low tar alternatives to smokers concerned about their health. The company even ignored most of the ethical concerns that were raised by senior scientists, a part of the parent organization.

'Overall, these documents depict a deliberate strategy whereby BAT and ITL (Imperial Tobacco Limited) designed products that would fool their consumers and regulators into thinking these products were safer or less hazardous when they were not. Moreover, this product strategy remains in place today, as does the tool of its deception, the ISO cigarette testing protocols. The current review leaves little doubt that the ISO standards should be discarded in favor of new standards that meet the needs of consumers and regulators, rather than those of the tobacco industry, ' concluded the authors of the present study.


'"/>




Page: 1

Related medicine news :

1. FDA To Set New Guidelines To Revise Drug Companies Marketing Tactics
2. Junk Food Marketing to be banned
3. Government Should Restrict Junk Food Marketing
4. Kellogg Warned Against Its Marketing Strategies
5. Bayer Wins Positive Response For Marketing Its Cancer Drug
6. Co-op to Stop Marketing Diabetic Food
7. Measures to Streamline Marketing of Breast-Milk Substitutes
8. Marketing in Schools may Discourage Healthy Nutrition among Students
9. Viagra Marketing Campaign, ‘a Cause of Concern’, Say Anti-AIDS Grop
10. Effective Marketing of Multivitamins Essential
11. FDA Announces to Companies to Stop Marketing Products Containing Trimethobenzamide
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/22/2017)... TX (PRWEB) , ... January 22, 2017 , ... ... provide slow results. Often the results of a simple test will take days to ... Any Lab Test Now offers customers direct access to their lab tests, bypassing the ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... Phytocéane ... Indian Ocean, isolated from the rest of the world with ZANZIBAR SHOWER GEL. Inspired ... Phytocéane used key ingredients, Virgin Coconut Oil and moisturizing vegetal coral to create this ...
(Date:1/21/2017)... ... January 21, 2017 , ... The Nobel ... Dan Holtzclaw in media for its creos™ line of bone regenerative products. ... Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for a variety of ...
(Date:1/20/2017)... , ... January 20, 2017 , ... Doctor C LLC, ... attended the January ECRM trade show to continue the marketing and distribution of its ... supplement, known for providing 400 percent better absorption than traditional vitamin C supplements. At ...
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser celebrated 5 years ... Betsy, the clinical trial has been life-saving as she has been on the ... Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent standard chemotherapy but ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... 2017 ResMed (NYSE: RMD ), BMC ( ... Haven, Florida ) today announced they have agreed on a ... will be permitted to sell their existing products in exchange for ... payment to 3B to close the Florida ... admission of liability or wrongdoing by any party. ...
(Date:1/21/2017)... , Jan. 20, 2017 ARMO BioSciences, Inc., ... data on the Company,s lead investigational immuno-oncology drug AM0010 ... by the American Society of Clinical Oncology (ASCO), taking ... CA. "AM0010 induces the ... + T cells in the blood and tumors ...
(Date:1/21/2017)... -- Research and Markets has announced the addition of ... Route Of Administration, End User - Forecast to 2025" report ... ... a CAGR of around 7.8% over the next decade to reach ... analyzes the global markets for Advanced Drug Delivery across all the ...
Breaking Medicine Technology: